CN Patent

CN109789213B — T4甲状腺激素的高稳定性包装解决方案

Assigned to IBSA Institut Biochimique SA · Expires 2022-05-31 · 4y expired

What this patent protects

本发明涉及高稳定性无醇的T4甲状腺激素的水‑甘油溶液，其具有减小量的T3杂质，通过特定容器设置包装。该容器为多屏障容器，在其中，特定材料的多个层将溶液与外界环境隔离接触。

USPTO Abstract

本发明涉及高稳定性无醇的T4甲状腺激素的水‑甘油溶液，其具有减小量的T3杂质，通过特定容器设置包装。该容器为多屏障容器，在其中，特定材料的多个层将溶液与外界环境隔离接触。

Drugs covered by this patent

Unithroid (LEVOTHYROXINE SODIUM) · Fresenius Kabi

Patent Metadata

Patent number: CN109789213B
Jurisdiction: CN
Classification: —
Expires: 2022-05-31
Drug substance claim: No
Drug product claim: No
Assignee: IBSA Institut Biochimique SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.